Efficacy and Safety Evaluation of CICAPLAST BAUME B5+ on Rosacea Accompanied by Sensitive Skin

In total, 72 eligible research participants were recruited in this 56-day study. The participants were divided into two groups-namely the Experimental Group and the Control Group-according to stratified randomization, with 36 participants in each group. Finally, 30 participants in each group were expected to complete the study. In this study, for patients with rosacea accompanied by sensitive skin, differences in repairing effects and other improvements were evaluated after they used LA ROCHE-POSAY CICAPLAST BAUME B5+ and a standard cream for 28 days, as well as differences between the two groups after both groups used LA ROCHE-POSAY CICAPLAST BAUME B5+ for an additional 28 days-via objective instrumental measurements and subjective assessments. Additionally, the safety of the investigational product was evaluated among these individuals.

NCT Number	NCT07106957
Lead Sponsor	Beijing Sino-German Union Cosmetic Institute Co., Ltd.
Conditions	Erythematous Telangiectatic Rosacea
Enrollment	72 participants
Start Date	2025-06-10
Primary Completion	2025-08-10 (estimated)
Study Completion	2025-08-10 (estimated)
Updated on ClinicalTrials.gov	2025-08-06